CD44 and non-small cell lung carcinoma: Similarly, siRNA was used to inhibit CD44 expression in EGFR wild-type NSCLC cells and the downregulation of CD44 attenuated cell growth, promoted cell cycle arrest at the G0/G1 stage and stimulated cell apoptosis.